135 related articles for article (PubMed ID: 22292400)
1. [Clinical application of imiquimod for the treatment of infantile hemangiomas].
Ma G; Lin XX; Jiang CH; Chen H; Li W; Hu XJ; Jin YB; Chen D; Chen XD; Ye XX
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Nov; 27(6):411-4. PubMed ID: 22292400
[TBL] [Abstract][Full Text] [Related]
2. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
Ho NT; Lansang P; Pope E
J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
[TBL] [Abstract][Full Text] [Related]
3. A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.
Jiang C; Hu X; Ma G; Chen D; Jin Y; Chen H; Chen X; Lin X
Pediatr Dermatol; 2011; 28(3):259-66. PubMed ID: 21615472
[TBL] [Abstract][Full Text] [Related]
4. Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars.
Qiu Y; Ma G; Lin X; Jin Y; Chen H; Hu X
Pediatr Dermatol; 2013; 30(3):342-7. PubMed ID: 23046440
[TBL] [Abstract][Full Text] [Related]
5. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma.
McCuaig CC; Dubois J; Powell J; Belleville C; David M; Rousseau E; Gendron R; Jafarian F; Auger I
Pediatr Dermatol; 2009; 26(2):203-12. PubMed ID: 19419474
[TBL] [Abstract][Full Text] [Related]
6. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream.
Welsh O; Olazarán Z; Gómez M; Salas J; Berman B
J Am Acad Dermatol; 2004 Oct; 51(4):639-42. PubMed ID: 15389206
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.
Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X
Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540
[TBL] [Abstract][Full Text] [Related]
8. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream.
Hazen PG; Carney JF; Engstrom CW; Turgeon KL; Reep MD; Tanphaichitr A
Pediatr Dermatol; 2005; 22(3):254-6. PubMed ID: 15916578
[TBL] [Abstract][Full Text] [Related]
9. Topical imiquimod treatment of cutaneous vascular disorders in pediatric patients: clinical evaluation on the efficacy and safety.
Mao XH; Wang JY; Yan JL
J Zhejiang Univ Sci B; 2012 Sep; 13(9):745-50. PubMed ID: 22949365
[TBL] [Abstract][Full Text] [Related]
10. Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches.
Craiglow BG; Antaya RJ
Paediatr Drugs; 2013 Apr; 15(2):133-8. PubMed ID: 23456550
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases.
Senchak AJ; Dann M; Cable B; Bessinger G
Ear Nose Throat J; 2010 Mar; 89(3):E21-5. PubMed ID: 20229466
[TBL] [Abstract][Full Text] [Related]
12. Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma.
Hu L; Huang HZ; Li X; Lin XX; Li W
Dermatology; 2015; 230(2):150-5. PubMed ID: 25633200
[TBL] [Abstract][Full Text] [Related]
13. Ulcerated infantile hemangioma treated with imiquimod.
Mascarenhas R; Guiote V; Agro J; Henrique M
Dermatol Online J; 2011 Sep; 17(9):13. PubMed ID: 21971278
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
[TBL] [Abstract][Full Text] [Related]
15. A prospective self-controlled study of topical timolol 0.5% cream for large superficial infantile hemangiomas.
Qiu Y; Yang J; Chen M; Chang L; Wang T; Ma G; Jin Y; Chen H; Lin X
J Dermatol; 2015 Apr; 42(4):363-6. PubMed ID: 25656976
[TBL] [Abstract][Full Text] [Related]
16. Involution of infantile haemangiomas after imiquimod 5% cream.
Barry RB; Hughes BR; Cook LJ
Clin Exp Dermatol; 2008 Jul; 33(4):446-9. PubMed ID: 18485022
[TBL] [Abstract][Full Text] [Related]
17. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
[TBL] [Abstract][Full Text] [Related]
20. A self-controlled study of intralesional injection of diprospan combined with topical timolol cream for treatment of thick superficial infantile hemangiomas.
Xu P; Yu Q; Huang H; Zhang W; Li W
Dermatol Ther; 2018 May; 31(3):e12595. PubMed ID: 29708630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]